Advertisement
Canada markets closed

  • S&P/TSX

    22,465.37
    +165.57 (+0.74%)
     

  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     

  • DOW

    40,003.59
    +134.19 (+0.34%)
     

  • CAD/USD

    0.7345
    -0.0003 (-0.04%)
     

  • CRUDE OIL

    80.20
    +0.14 (+0.17%)
     

  • Bitcoin CAD

    91,092.23
    -454.17 (-0.50%)
     

  • CMC Crypto 200

    1,367.40
    +12.99 (+0.96%)
     

  • GOLD FUTURES

    2,443.00
    +25.60 (+1.06%)
     

  • RUSSELL 2000

    2,095.72
    -0.53 (-0.03%)
     

  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     

  • NASDAQ

    16,685.97
    -12.33 (-0.07%)
     

  • VOLATILITY

    12.23
    +0.24 (+2.00%)
     

  • FTSE

    8,446.86
    +26.60 (+0.32%)
     

  • NIKKEI 225

    39,069.68
    +282.30 (+0.73%)
     

  • CAD/EUR

    0.6752
    -0.0003 (-0.04%)
     

Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2 min read

For the quarter ended March 2024, Agilon Health (AGL) reported revenue of $1.6 billion, up 41.2% over the same period last year. EPS came in at $0.01, compared to $0.04 in the year-ago quarter.

The reported revenue represents a surprise of -0.85% over the Zacks Consensus Estimate of $1.62 billion. With the consensus EPS estimate being -$0.02, the EPS surprise was +150.00%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Agilon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Average Medicare Advantage membership: 518,400 versus 513,855 estimated by three analysts on average.

  • Direct Contracting beneficiaries (ACO REACH): 131,000 compared to the 119,150 average estimate based on two analysts.

  • Medicare Advantage Members: 522,800 compared to the 527,365 average estimate based on two analysts.

  • Revenues- Medical services: $1.60 billion compared to the $1.61 billion average estimate based on five analysts. The reported number represents a change of +41.1% year over year.

  • Revenues- Other operating: $3.16 million versus $1.92 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +139.9% change.

View all Key Company Metrics for Agilon here>>>

Shares of Agilon have returned -6.8% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Agilon Health, Inc. (AGL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research